Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 5 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Cramer explains how to maintain a 'balanced' portfolio as the economy slows
CNBC· 3 hours agoCNBC's Jim Cramer on Tuesday said Wall Street is currently going through a tricky stage of the...
Dow Jones Drug Giant Merck, Nvidia Eye Buy Points In Current Stock Market
Investor's Business Daily· 1 day agoAmong the best stocks to watch, Dow Jones drug giant Merck, Nvidia, Chipotle Mexican Grill and NXP...
Merck First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 2 days agoMerck (NYSE:MRK) First Quarter 2024 Results Key Financial Results Revenue: US$15.8b (up 8.9% from 1Q...
Opko Health (OPK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 31 minutes agoWe look forward to keep you apprised of progress with these promising programs. ModeX continues to advance its development work, and two programs are on...
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha· 5 days agoPrivately held Cerevance receives milestone payment from Merck for Alzheimer's research...
Is Merck Stock Fully Valued At $130?
Forbes· 7 days agoMerck (NYSE: MRK) recently reported its Q1 results, with revenues and earnings exceeding our estimates. The growth was primarily driven by higher sales...
Dow Jones Futures Rise: AI Stock Palantir Plunges On Earnings; Apple 'Let Loose' Event Next
Investor's Business Daily· 14 hours agoChipotle Mexican Grill, NXP Semiconductor, Texas Roadhouse and Tradeweb Markets — plus Dow Jones...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 6 days agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
Armata Pharmaceuticals Q1 2024 Earnings: Narrower Losses and Strategic Advances
GuruFocus.com via Yahoo Finance· 38 minutes agoThe company's innovative approach utilizes both natural and synthetic phage candidates, with ongoing clinical programs targeting Pseudomonas aeruginosa and Staphylococcus aureus, among others ...
